BrainStorm Cell Therapeutics Inc (BCLI)

[jfk]

Lets just say that it is potentially big science for huge markets, so big appreciation is in the cards......so long as results continue to develop positive. But unless they get funding from an institution for another disease indication, we have to wait on ALS results, which are 2019. That's why I think RTT gives us a big opening to dive into. But, yes, if we get funded for another big indication, we could get to $30 within 2-3 years....easy.